ARS Pharmaceuticals Inc
NASDAQ:SPRY 3:58:25 PM EDT
| Market Cap (Intraday) | 1.76B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $17.37 |
| 50-Day MA | $15.17 |
| 200-Day MA | $13.69 |
ARS Pharmaceuticals Inc Stock, NASDAQ:SPRY
11682 El Camino Real, Suite 120, San Diego, California 92130
United States of America
Phone: +1.206.456.2900
Number of Employees: 26
Description
ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.